Denmark excludes Johnson & Johnson vaccine over clot concerns
Denmark has become the first country to remove the Johnson & Johnson COVID-19 vaccine from its national programme due to a potential link with rare blood clots. The move follows similar action taken against the AstraZeneca vaccine.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthDenmark excludes Johnson & Johnson vaccine over clot concerns
Sign in or subscribeBrowse free archive reportsDenmark has become the first country to remove the Johnson & Johnson COVID-19 vaccine from its national programme due to a potential link with rare blood clots. The move follows similar action taken against the AstraZeneca vaccine.